M. Suttorp

526 total citations
14 papers, 368 citations indexed

About

M. Suttorp is a scholar working on Hematology, Nephrology and Oncology. According to data from OpenAlex, M. Suttorp has authored 14 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 5 papers in Nephrology and 4 papers in Oncology. Recurrent topics in M. Suttorp's work include Erythropoietin and Anemia Treatment (7 papers), Dialysis and Renal Disease Management (5 papers) and Acute Kidney Injury Research (3 papers). M. Suttorp is often cited by papers focused on Erythropoietin and Anemia Treatment (7 papers), Dialysis and Renal Disease Management (5 papers) and Acute Kidney Injury Research (3 papers). M. Suttorp collaborates with scholars based in Netherlands, Germany and Israel. M. Suttorp's co-authors include Friedo W. Dekker, Carmine Zoccali, Kitty J. Jager, Bob Siegerink, Tiny Hoekstra, Catherijne A. J. Knibbe, Jaap Jan Boelens, Toine C. G. Egberts, J. Zwaveling and Marc Bierings and has published in prestigious journals such as PLoS ONE, Nephrology Dialysis Transplantation and Thrombosis Research.

In The Last Decade

M. Suttorp

14 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Suttorp Netherlands 9 140 68 52 44 40 14 368
Hélène Derumeaux France 10 75 0.5× 50 0.7× 13 0.3× 32 0.7× 33 0.8× 22 404
Jennifer Nicol Australia 11 54 0.4× 55 0.8× 40 0.8× 77 1.8× 28 0.7× 27 389
Ahmed A. Awan United States 8 54 0.4× 33 0.5× 69 1.3× 18 0.4× 25 0.6× 19 308
Thomas Bush United States 12 43 0.3× 113 1.7× 18 0.3× 38 0.9× 15 0.4× 18 632
Cianna Leatherwood United States 13 56 0.4× 35 0.5× 37 0.7× 70 1.6× 20 0.5× 22 508
Hui Yin Lim Australia 12 122 0.9× 26 0.4× 22 0.4× 9 0.2× 20 0.5× 56 399
Vasco Miranda Portugal 18 202 1.4× 42 0.6× 289 5.6× 49 1.1× 36 0.9× 53 786
Thomas Huneck Haupt Denmark 9 41 0.3× 34 0.5× 31 0.6× 21 0.5× 33 0.8× 13 410
Hakan Cinemre Türkiye 13 40 0.3× 44 0.6× 30 0.6× 21 0.5× 143 3.6× 48 533
Anne Haaber Denmark 10 33 0.2× 50 0.7× 36 0.7× 30 0.7× 45 1.1× 14 374

Countries citing papers authored by M. Suttorp

Since Specialization
Citations

This map shows the geographic impact of M. Suttorp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Suttorp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Suttorp more than expected).

Fields of papers citing papers by M. Suttorp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Suttorp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Suttorp. The network helps show where M. Suttorp may publish in the future.

Co-authorship network of co-authors of M. Suttorp

This figure shows the co-authorship network connecting the top 25 collaborators of M. Suttorp. A scholar is included among the top collaborators of M. Suttorp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Suttorp. M. Suttorp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Horváth–Puhó, Erzsébet, M. Suttorp, Henrik Frederiksen, et al.. (2018). Erythropoiesis-stimulating agents and cardiovascular events in patients with myelodysplastic syndrome and multiple myeloma. Clinical Epidemiology. Volume 10. 1371–1380. 10 indexed citations
2.
Evans, Marie, M. Suttorp, Rino Bellocco, et al.. (2015). Trends in haemoglobin, erythropoietin-stimulating agents and iron use in Swedish chronic kidney disease patients between 2008 and 2013. Nephrology Dialysis Transplantation. 31(4). 628–635. 24 indexed citations
3.
Suttorp, M., Tiny Hoekstra, Moshe Mittelman, et al.. (2015). Treatment with high dose of erythropoiesis-stimulating agents and mortality: analysis with a sequential Cox approach and a marginal structural model. Pharmacoepidemiology and Drug Safety. 24(10). 1068–1075. 18 indexed citations
4.
Hoekstra, Tiny, Joris I. Rotmans, Mark de Boer, et al.. (2014). The association between dialysis modality and the risk for dialysis technique and non-dialysis technique-related infections. Nephrology Dialysis Transplantation. 29(12). 2244–2250. 10 indexed citations
5.
Suttorp, M., Tiny Hoekstra, Gürbey Ocak, et al.. (2014). Erythropoiesis-stimulating agents and thrombotic events in dialysis patients. Thrombosis Research. 134(5). 1081–1086. 5 indexed citations
6.
Suttorp, M., Bob Siegerink, Kitty J. Jager, Carmine Zoccali, & Friedo W. Dekker. (2014). Graphical presentation of confounding in directed acyclic graphs. Nephrology Dialysis Transplantation. 30(9). 1418–1423. 150 indexed citations
7.
Scherhag, Armin, Tiny Hoekstra, M. Suttorp, et al.. (2014). The influence of Erythropoietin on platelet activation, thrombin generation and FVII/active FVII in patients with AMI. Thrombosis Journal. 12(1). 18–18. 11 indexed citations
8.
Suttorp, M., Tiny Hoekstra, Moshe Mittelman, et al.. (2013). Effect of Erythropoiesis-Stimulating Agents on Blood Pressure in Pre-Dialysis Patients. PLoS ONE. 8(12). e84848–e84848. 6 indexed citations
9.
Suttorp, M., Tiny Hoekstra, Joris I. Rotmans, et al.. (2013). Erythropoiesis-stimulating agent resistance and mortality in hemodialysis and peritoneal dialysis patients. BMC Nephrology. 14(1). 20 indexed citations
10.
Bartelink, Imke H., Robbert G. M. Bredius, Svetlana V. Belitser, et al.. (2009). Association between Busulfan Exposure and Outcome in Children Receiving Intravenous Busulfan before Hematologic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 15(2). 231–241. 95 indexed citations
11.
Wichmann, Manfred, et al.. (1996). Can Blood Group 0 Red Cells of Donor Origin Acquire Weak Group A Reactivity through Serum A Transferase of the Recipient after Bone Marrow Transplantation?. Transfusion Medicine and Hemotherapy. 23(1). 29–31. 2 indexed citations
12.
Dreger, Peter, Nils von Neuhoff, M. Suttorp, H. Löffler, & Norbert Schmitz. (1995). Rapid engraftment of peripheral blood progenitor cell grafts purged with B cell-specific monoclonal antibodies and immunomagnetic beads.. PubMed. 16(4). 627–9. 15 indexed citations
13.
Dreger, Peter, T. Haferlach, S. Jacobs, et al.. (1994). Peripheral blood progenitor cell but not bone marrow grafts are affected by previous Dexa-BEAM chemotherapy. 145. 1 indexed citations
14.
Dreger, Peter, Joerg Steinmann, Nicole Schmitz, et al.. (1993). CD48 monoclonal antibody K31 for bone marrow transplantation: T-depleting capacity and influence on hematopoietic progenitors.. PubMed. 12 Suppl 3. S13–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026